Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700033634

Trial Profile

Clinical Trials Insight: 700033634

Phase of Trial: Phase I

Latest Information Update: 12 Mar 2009

At a glance

  • Drugs TC 6499 (Primary)
  • Indications Neuropathic pain
  • Focus Adverse reactions
  • Sponsors Targacept
  • Most Recent Events

    • 12 Mar 2009 Status changed from planning to completed, based on a Targacept media release.
    • 12 Mar 2009 Based on the results of this study, Targacept has discontinued development of TC 6499 for the treatment of neuropathic pain.
    • 16 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top